We are pleased to share our new article:
Health care resource utilization preceding death or lung transplantation in people with cystic fibrosis HCRU before transplant or death in cystic fibrosis
published in Journal of CysticFibrosis.
Thanks to the co-authors and to the CNAM for the SNDS data.
PELyon is pleased to announce its agreement with LYSARC for the conduct of research projects based on the linkage of clinical data relating to lymphomas from LYSARC with the SNDS.
This partnership aims to carry out research projects between our two structures, but also to collaborate on external projects, in particular with pharma industry.
The agreement was signed in September 2023, for a period of 3 years.
The benefits of this collaboration: Conducting innovative and in-depth lymphoma research projects, using both SNDS data and detailed clinical data.
A first project is underway on the REALYSA cohort, with the objective to extend the cohort’s data, particularly on comorbidities, healthcare consumption, and long-term follow-up.
